248 related articles for article (PubMed ID: 3360051)
1. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
Pieters FA; Woonink F; Zuidema J
Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051
[TBL] [Abstract][Full Text] [Related]
2. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Mehta J; Gandhi IS; Sane SB; Wamburkar MN
Lepr Rev; 1986; 57 Suppl 3():67-76. PubMed ID: 3573964
[No Abstract] [Full Text] [Related]
3. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
Chandorkar AG; Burte NP; Gade RK; Bulakh PM
Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
[TBL] [Abstract][Full Text] [Related]
4. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Mehta J; Gandhi IS; Sane SB; Wamburkar MN
Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and interactions of antileprosy drugs.
George J
Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
[TBL] [Abstract][Full Text] [Related]
7. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
Paul S; Rose ET
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
[No Abstract] [Full Text] [Related]
8. Comparison of two multidrug regimens in multibacillary leprosy.
Jadhav VH; Patki AH; Mehta JM
Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.
Leiker DL
Lepr Rev; 1986; 57 Suppl 3():272-3. PubMed ID: 3573955
[No Abstract] [Full Text] [Related]
10. Study on drug interactions.
Venkatesan K; Bharadwaj VP; Ramu G; Desikan KV
Lepr India; 1980 Apr; 52(2):229-35. PubMed ID: 7453137
[TBL] [Abstract][Full Text] [Related]
11. The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy.
Venkatesan K; Mathur A; Girdhar BK; Bharadwaj VP
J Antimicrob Chemother; 1986 Dec; 18(6):715-8. PubMed ID: 3818497
[TBL] [Abstract][Full Text] [Related]
12. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance and multi-drug therapy in leprosy.
Chatterjee BR
Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
[No Abstract] [Full Text] [Related]
14. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
Balakrishnan ; Seshadri PS
Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
[TBL] [Abstract][Full Text] [Related]
15. Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy.
Yawalkar SJ; McDougall AC; Languillon J; Ghosh S; Hajra SK; Opromolla DV; Tonello CJ
Lancet; 1982 May; 1(8283):1199-202. PubMed ID: 6122970
[TBL] [Abstract][Full Text] [Related]
16. Effect of three-year multidrug therapy in multibacillary leprosy patients.
Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Cruz RCDS; Bührer-Sékula S; Penna GO; Moraes MEA; Gonçalves HS; Stefani MMA; Penna MLF; Pontes MAA; Talhari S
An Bras Dermatol; 2018 Jun; 93(3):377-384. PubMed ID: 29924240
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
Singh RP; Tiwari VD; Chattopadhyay SP
Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
[TBL] [Abstract][Full Text] [Related]
20. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
